Abstract:Background: Single-cell technologies provide invaluable insights into disease biology and drug development by revealing complex interactions among different cell types within patients. However, harnessing the potential of publicly available single-cell data remains challenging due to the lack of integrated data across diverse single cell platforms. Methods: To maximize the potential of single cell insights, we have created an AI/ML powered curation and data integration process within our Drug Intelligence Science (DIS®) platform. This automated process integrates single cell transcriptomic data from publicly available sources with our in-house generated datasets from ex vivo translational efforts and clinical programs. Relevant public datasets are identified and retrieved using an automated Python-based GEO dataset crawler tool, and standardized metadata are curated. A reference atlas of 31 immune and 4 non-immune cell types is generated from the database and is used to consistently label cells across datasets. Additionally, cell-level gene expression integration and normalization across datasets is achieved using generative modeling techniques. To facilitate multiuser visualization and interrogation of the curated and integrated datasets, we have developed Cellect, a customized version of CellxGene Gateway. Results: The current single-cell database comprises 15 million cells analyzed in >5,000 samples collected from >2,500 patients across 160 curated unique human studies, spanning oncology (56%), autoimmune disease (AID, 21%), and viral infection (15%), with the remaining being from reference healthy tissues (8%). We focused dataset curation on indications of interest for our internal clinical development efforts. Uniquely, data from approximately 300 patients who received standard of care (SOC) treatment including immune checkpoint inhibitor (IO) therapy were integrated to delineate mechanisms of drug response and resistance. The post-SOC resource was used to identify (1) treatment settings where these mechanisms are enriched and (2) markers co-expressed with targets of interest (e.g., PD1, CTLA4, OX40, TNFR2, etc.) in specific cell populations to inform combination strategies. Conclusions: We have presented an AI/ML guided approach to address the key challenge of integrating single-cell data across platforms and demonstrated that relevant disease biology is retained upon integration. We outline a path for deploying this solution at scale for bench and computational scientists to guide target as well as indication selection, as was done for our ongoing clinical programs, including our first-in-class TNFR2 agonist (HFB200301, NCT05238883) and second-generation OX40 agonist (HFB301001, NCT05229601). Citation Format: Jack Russella-Pollard, Joshua Whitener, Jordan Byck, Monika Manne, Hani Alostaz, Marianna Elia, Kamil Krukowski, Gabrielle Wong, Francisco Adrian, Liang Schweizer, Robert H. Andtbacka, Christos Hatzis. Integrating public single-cell transcriptomics and patient profiles to guide clinical development [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6202.

[Omics and cell controlling technology for drug discovery]

Single-cell Technology for Drug Discovery and Development

Phosphorylated Protein Chip Combined with Artificial Intelligence Tools for Precise Drug Screening

Single Cell Multi-Omics Technology: Methodology and Application

Applications of single-cell RNA sequencing in drug discovery and development

Advanced Single-cell Omics Technologies and Informatics Tools for Genomics, Proteomics, and Bioinformatics Analysis

Single Cell Omics: From Assay Design to Biomedical Application

Development of Multiomics in Situ Pairwise Sequencing (Mip-Seq) for Single-cell Resolution Multidimensional Spatial Omics

Quartz-Seq2: a high-throughput single-cell RNA-sequencing method that effectively uses limited sequence reads

CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Single-cell Multiomics: a New Frontier in Drug Research and Development

Overloading And unpacKing (OAK) - droplet-based combinatorial indexing for ultra-high throughput single-cell multiomic profiling

Deciphering the single-cell omic: innovative application for translational medicine

Exploiting Single-Cell Tools in Gene and Cell Therapy

PHDs-seq: a Large-Scale Phenotypic Screening Method for Drug Discovery Through Parallel Multi-Readout Quantification

Abstract 6202: Integrating public single-cell transcriptomics and patient profiles to guide clinical development

“Omics” in Pharmaceutical Research: Overview, Applications, Challenges, and Future Perspectives

Advances and Trends in Omics Technology Development

Achieving a Deeper Understanding of Drug Metabolism and Responses Using Single-Cell Technologies

Integrated Analysis of Whole Genome and Epigenome Data Using Machine Learning Technology: Toward the Establishment of Precision Oncology